Clifton O. Bingham-Iii

Clifton O. Bingham-Iii

Rheumatology

4940 Eastern Avenue, Bayview Medical Offices, Level 01 (G), Clinic 5
Bayview Medical Offices, Level 01 (G), Clinic 5
Baltimore, MD 21224

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis.

Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis.

Journal: Arthritis research & therapy

Published: November 25, 2024

Comparative assessment of physiochemical metrics for the clustering of adaptive immune receptor repertoires.

Comparative assessment of physiochemical metrics for the clustering of adaptive immune receptor repertoires.

Journal: Nucleic acids research

Published: November 01, 2024

Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials.

Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials.

Journal: Seminars in arthritis and rheumatism

Published: October 29, 2024

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.

Journal: Rheumatology and therapy

Published: November 11, 2022

Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.

Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.

Journal: Seminars in arthritis and rheumatism

Published: March 30, 2022

Feasibility and acceptability of using a meditation app in adults with rheumatic disease.

Feasibility and acceptability of using a meditation app in adults with rheumatic disease.

Journal: Explore (New York, N.Y.)

Published: May 27, 2021

The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies.

The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies.

Journal: Arthritis research & therapy

Published: May 25, 2021

The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2.

The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2.

Journal: Seminars in arthritis and rheumatism

Published: May 03, 2021

Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.

Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.

Journal: Clinical and experimental rheumatology

Published: November 20, 2019

Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.

Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.

Journal: Trials

Published: May 24, 2019

Pattern of muscle involvement in inclusion body myositis: a sonographic study.

Pattern of muscle involvement in inclusion body myositis: a sonographic study.

Journal: Clinical and experimental rheumatology

Published: May 21, 2019

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).

Journal: Clinical and experimental rheumatology

Published: May 06, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026